Once-daily dosing that allows patients to start at the effective dose, regardless of bipolar I or II depression1
- Taken orally with or
- See full prescribing information for dosing in patients with moderate or severe hepatic impairment or concomitant use with CYP3A4 inhibitors or inducers.
Reference: 1. CAPLYTA prescribing information, 2022.